Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766107
Title: Studies in the aetiology, investigation and treatment of perianal fistula
Author: Haddow, James Boyd
ISNI:       0000 0004 7653 5538
Awarding Body: Queen Mary University of London
Current Institution: Queen Mary, University of London
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Background: Perianal fistulae are common and cause significant symptoms and psychosocial morbidity. Current theory suggests two distinct types: idiopathic (no established cause) and secondary, which usually arise from Crohn's disease. Research to date has assumed that idiopathic and Crohn's perianal fistulae differ in their pathogenesis and pathophysiology. This fundamental hypothesis has not yet been adequately tested. We therefore aimed to test the broad hypothesis that idiopathic and Crohn's perianal fistulae differ in their pathogenesis and pathophysiology. Methods: We prospectively recruited a cohort of 61 participants (48 idiopathic, 13 Crohn's disease) and phenotyped them in detail using clinical assessment, Perineal Disease Activity Index, EQ-5D-5L, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), operative assessment, biopsy, and clinical follow-up. We interrogated the biopsy samples in the laboratory to characterize their profiles for 30 cytokines and 39 phosphoproteins. Over 12,000 clinical and 23,500 laboratory measurements were made. Results: We found no clear differences in the clinical characteristics or the overall cytokine or phosphoprotein profiles between idiopathic and Crohn's perianal fistulae. We also found no differences in the DCE-MRI measurements between the groups. Conclusions: We did not find good evidence to support our hypothesis. The alternative hypothesis offers a shift in the current research paradigm: idiopathic and Crohn's perianal fistulae are the same pathology on a spectrum across which the pathogenic and pathophysiological features are distributed in a skewed manner. This may be the key to unravelling our understanding of the disease's aetiology. It would also be a construct within which trials of biological therapy, such as infliximab, could be justified for idiopathic disease.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (M.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.766107  DOI: Not available
Keywords: Digestive Diseases ; Perianal Fistula ; Crohn's
Share: